Check Atara Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$80.8M
EPS (TTM)
2.53
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
15.99
Industry PE ratio
-4.2220604395604395
P/B Ratio
15.9861
PEG Ratio
0EBITDA
24.0M
Revenue (TTM)
188.7M
Profit Margin
3.07%
Return On Equity TTM
-2014.86%
Track how Atara Biotherapeutics Inc P/E has moved over time to understand its valuation trends.
Atara Biotherapeutics Inc in the last 5 years
Lowest (0.00x)
September 18, 2025
Industry (-4.22x)
September 18, 2025
Today (15.99x)
September 18, 2025
Highest (0.00x)
September 18, 2025
Today’s Price to Earnings Ratio: 15.99x
Compare market cap, revenue, PE, and other key metrics of Atara Biotherapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $80.8M | -97.08% | 15.99 | 3.07% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Atara Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Atara Biotherapeutics Inc investment value today
Current value as on today
₹1,57,812
Returns
₹57,812
(+57.81%)
Returns from Atara Biotherapeutics Inc Stock
₹52,859 (+52.86%)
Dollar Returns*
₹4,953 (+4.95%)
Based on 13 analysts
61.54%
Buy
30.77%
Hold
7.69%
Sell
Based on 13 analysts, 61.54% of analysts recommend a 'BUY' rating for Atara Biotherapeutics Inc. Average target price of $16.33
Get share price movements and forecasts by analysts on Atara Biotherapeutics Inc.
What analysts predicted
26.33%UPSIDE
Target Price
$16.33
Current Price
$12.03
Analyzed by
13 Analysts
Target
$16.33
Atara Biotherapeutics Inc target price $16.33, a slight upside of 26.33% compared to current price of $12.03. According to 13 analysts rating.
Search interest for Atara Biotherapeutics Inc Stock has decreased by -35% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 21.1%
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 200.0%
Profit Down
Netprofit is down for the last 2 quarters, 38.01M → 2.38M (in $), with an average decrease of 93.7% per quarter
Revenue Fall
Revenue is down for the last 2 quarters, 98.14M → 17.57M (in $), with an average decrease of 82.1% per quarter
Price Dip
In the last 3 years, ATRA stock has moved down by -88.5%
Organisation | Atara Biotherapeutics Inc |
Headquarters | 1280 Rancho Conejo Blvd, Thousand Oaks, CA, United States, 91320 |
Industry | Health Technology |
CEO | Dr. Anhco Nguyen Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Anhco Nguyen Ph.D. | President, CEO & Director |
Ms. Yanina Grant-Huerta | Chief Accounting Officer & Principal Accounting Officer |
Alex Chapman | Vice President of Corporate Communications & Investor Relations |
Mr. John Chao | Head of Legal |
Mr. Jim Sesic | Senior Vice President of Regulatory Affairs |
Atara Biotherapeutics Inc share price today is $12.03 as on at the close of the market. Atara Biotherapeutics Inc share today touched a day high of $12.05 and a low of $11.33.
Atara Biotherapeutics Inc share touched a 52 week high of $18.71 on and a 52 week low of $5.01 on . Atara Biotherapeutics Inc stock price today i.e. is closed at $12.03,which is 35.69% down from its 52 week high and 140.36% up from its 52 week low.
Atara Biotherapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Atara Biotherapeutics Inc (ATRA) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Atara Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Atara Biotherapeutics Inc share’s latest price of $12.03 as on September 19, 2025 at 1:29 am IST, you will get 0.8313 shares of Atara Biotherapeutics Inc. Learn more about
fractional shares .
Atara Biotherapeutics Inc stock has given -97.08% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?